BEGIN:VCALENDAR VERSION:2.0 PRODID:icalendar-ruby CALSCALE:GREGORIAN BEGIN:VEVENT DTSTAMP:20240328T153521Z UID:df0d601b-6d43-4778-aae1-9ab7eac8c59f DTSTART:20210326T090000 DTEND:20210327T090000 CLASS:PRIVATE DESCRIPTION:\n
PULSUS \;group is glad to invite all the participants acro ss the globe to attend \;&lsquo\;23rd International conference on Cancer Research &\; Pharmacology&rsquo\; \;during \;Ma rch 26-27\, 2021 \;in \;Edinburgh\, Scotland \;w hich includes prompt keynote presentations\, Oral talks\, Poster presentat ions and Exhibitions.
\n\nC ancer Research 2021 \;is an extraordinary event designed for Inte rnational medical health professionals and oncologists to facilitate the d issemination and application of research findings related to Cancer. The&n bsp\;cancer conference \;invites participants from all leading univers ities\, clinical research institutions and diagnostic companies to share t heir research experiences on all aspects of this rapidly expanding field a nd thereby\, providing a showcase of the latest techniques.
\n\n \;
\n\nWhy to attend??
\nThis \;cancer conferences \;will enlighten the public wit
h recent advances in Cancer diagnosis and therapy from around the world an
d to sharpen the related ideas about cancer research. Moreover this \;
oncology conferenceprovides you a great networking with peers. World-renow
ned speakers\, the most recent techniques\, and the newest updates in canc
er research fields are the trademark of this conference. \;Cancer conf
erences\, symposiums and Workshops provide a dedicated forum for the advan
cement\, execution and exchange of information about Oncology and Cancer.<
/span>
Cancer Research 2021 \; is a hallmark in the era of \;cancer conferences \;with its eminen t speakers and notable organizing committee members.
\n\n
\nOncologists\
, Radiologists\, Chemotherapists\, Physicians\, Academicians\, Academic sc
ientists\, Industry professionals\, Diagnostic laboratory professionals\,
Undergraduate &\; Postgraduate students\, researchers\, business profes
sionals\, Postdoctoral fellows and Trainees\, Cancer Diagnostics Associati
ons and Societies.
 \;
\n\nPULSUS \;which organizes 1000+ Global events every year is delighted to welcome all the enthusiastic participants across the world to its prestigious \;Cancer Conference \;named \;&ls quo\;23rd International conference on Cancer Research &\; Pharmacology& rsquo\; \;which is going to be held during November 26-27\, 2021 at \;Edinburgh\, Scotland. \;Cancer Research 2021&nbs p\;highlights the theme \;&ldquo\; \;Informative Ses sions on Cancer and Pharmacology Research: Challenges and Achievements &rdquo\;.
\n\nPULSUS provi des an opportunistic environment and vibrant podium through these auspicio us events to amplify these steps and meet the highest demand ever\, by ref lexive and cerebrative connections. PULSUS has been progressively organizi ng scientific conferences across the globe\, rendezvous which consist of v arious streams of scientific study to improve and accelerate discovery for a better tomorrow. The non-profit firm plans for organizing an average of 1000 international conferences per year which is supported by 700 open ac cess journals and 80\,000 Editorial Board Members. The number of reader vi ews of the website has clocked 7.5 million and still counting. Lately arou nd more than 1000 scientific associations of various fields from all over the world have shown interest in association with PULSUS to promote their research work. PULSUS conferences offer exciting features like internation al symposia\, B2B meetings\, trade shows\, exhibitions\, and international workshops to build global networking and meaningful academic research and industry alliances. PULSUS initiated the \;'\;Young Scientist awar ds'\; \;to the enterprising young science researchers and scholars across the globe.
\n\nCance r Research 2021 \;provides an excellent opportunity to share view s\, exchange knowledge and establish research collaborations &\; networ king.
\n\nThe main aim of t his conference is \;Informative Sessions on Cancer and Pharmacolo gy Research: Challenges and Achievements.
\n\nCancer Research 2021 \;is a unique \;oncol ogy conference \;forum to bring together worldwide distinguished acade mics in the field of public health professionals\, academic scientists\, i ndustry researchers\, scholars to exchange about the state of the art rese arch and technologies.
\n\nTarget Audience:
\n\n&midd ot\; Radiologists
\n\n·\; Oncologists
\n\n·\; Chem otherapists
\n\n·\; Docto rs
\n\n·\; Oncology Insti tutes
\n\n·\; Medical Col leges
\n\n·\; Research fa culty
\n\n·\; Academic Sc ientists
\n\n·\; Students
\n\n·\; Diagnostic labor atory professionals
\n\n· \; Business Entrepreneurs
\n\n& middot\; Industry professionals
\n\n·\; Directors/Managers/CEO&rsquo\;s
\n\n·\; Presidents &\; Vice Presidents
\n\n·\; Brand Manufacturers/ Market ers of Consumer Products
\n\n&m iddot\; Marketing\, Advertising and Promotion Agency Executives.
\n\n \;
\n\nCancer \;is a branch of biology with branches such as organ specific cancer\, cancer genomics\, c ancer pharmacology\, cancer immunotherapy etc. This conference will witnes s a collection of various branches in cancer and it involves a vast range of medical streams within it. This conference will be an excellent platfor m for interdisciplinary interactions\, networking with renowed persons and also to share scientific research knowledge\, views and ideas in a single roof.
\n\nThe organizing commi ttee is decking out for an exciting and informative \;cancer conferenc e \;program including plenary lectures\, symposia\, workshops on a var iety of topics\, poster presentations and various programs for participant s from all over the world. We invite you to join us at the \;Cancer Re search 2021\, \;where you will be gaining a lot of new innovative idea s and knowledge from the scientists and scholars all over the world.
\n\nCancer\,a major health problem i s the most killer disease of this 21st \;century. The most common type s of cancer being lung cancer causing 1.4 million deaths per year\, stomac h cancer causing 740\,000 deaths\, liver cancer causing 700\,000 deaths\, colorectal cancer causing 610\,000 and breast cancer causing 460\,000 deat hs. This proves invasive cancer to be the leading cause of death in the pr esent century .
\n\n\n\n
Previo usly deaths by cancer were less. Presently\, the mortality rate because of cancer are increasing due to changed lifestyles and longer lifespans. Can cer mortality can be reduced if the disease is detected and treated early. Although cancer can strike any age group yet the risks of being affected b y cancer increases with age\,its main reason attributing to immunosenesenc e.The risks of prostrate cancer in ageing men is as high as 80%.
\n\nChildren and middle age group indivi duals are highly prone to cancers like Leukemia(34%)\,brain tumors(23%) an d lymphomas(12%). These are the most occurring types of cancer in middle a ged individuals also. Breast cancer prevalent in women ranks second as a c ause of cancer death in women.
\n\n\n\n
Importance &\; Scope:
\n\nCancer Research 2021 \;conference \;provides the best platfo rm for the experts\, researchers\, students and business delegates with it s well organized scientific program including detail information about the current scenario of cancer research and the advancement in the field of c ancer research and also it covers the basic reason behind the cancer to th e current trend in diagnosing and treating the cancer. This international event has a main motto on encountering the chronic disease like blood canc er\, lung cancer and cervical cancer and so on and also it assist in findi ng the new technique in the treatment of cancer and in the diagnosis of ca ncer. This conference also deals with the pharmacology under cancer resear ch\, this helps in finding the weapon against cancer.
\n\nConference highlights:
\n\n1.Cancer Biology
\n\n2.Carcinogenesis
\n\n3.Oncog enomics
\n\n4.Organ Based Cance rs
\n\n5.Hereditary Cancers
\n\n6.Cancer Epigenetics
\n\n7.Cancer Metastasis
\n\n8. Cancer Pharmacology
\n\n10.Cancer-Genomics And Metabolomics< /p>\n\n
11.Therapeutics Of Cancer p>\n\n
12.Neuro-oncology
\n\n13.Cancer Biomarkers
\n\n14.Novel Approaches Of Cancer Therapies
\n\n15.Precision Medicine And Cancer Ther apy
\n\n16. Stem Cell Transplan t Therapy
\n\n17.Cancer Managem ent And Prevention
\n\n18.Scree ning For Cancer
\n\n19. Alterna tive Medicine And Cancer
\n\n20 . Cancer Research
\n\n21. Cance r Nanotechnology
\n\n22.Cancer Imaging
\n\nGlance at Marke t of Cancer:
\n\nCancer is the second leading cause of death globally and accounted for 8.8 million death in 2021. Lung\, prostate\, colorectal\, stomach and liver cancer are the most common types of cancer in men\, while breast\, colorectal\, lung \, cervix and stomach cancer are the most common among women. Cancer affec ts everyone &ndash\; the young and old\, the rich and poor\, men\, women a nd children &ndash\; and represents a tremendous burden on patients\, fami lies and societies. Cancer is one of the leading causes of death in the wo rld. Yet\, many of these deaths can be avoided. Between 30-50% of cancers are preventable by healthy lifestyle choices such as avoidance of tobacco and public health measures like immunization against cancer causing infect ions. Others can be detected early\, treated and cured. Even with late sta ge cancer\, the suffering of patients should be relieved with good palliat ive care. The economic impact of cancer is significant and is increasing . The total annual economic cost of cancer is around US$ 1.16 trillion. In 2 021 about 8.8 million people died from cancer-nearly 1 in 6 global deaths. The number of new cases is expected to rise by about 70% over the next 2 decades. Only 1 in 5 low- and middle-income countries have the necessary d ata to drive cancer policy.
\n\n \;
\n\n1.Cancer Biology
\n\nCancer cells are typically defined by their capacity to divide un controllably. Cancerous tumors are malignant\, which means they can spread into\, or invade\, nearby tissues. In addition\, as these tumors grow\, s ome cancer cells can break off and travel to distant places in the body th rough the blood or the lymph system and form new tumors far from the origi nal tumor. They have the property of secondary malignant growths at a dist ance from a primary site of cancer.Cancer cells arise from the body&rsquo\ ;s own tissues. Cancer Cell Biology includes the molecular\, biochemical\, and cell-based approaches to better understand cancer pathogenesis
\n\n2.Oncology
\n\ nCarcinogenesis is the the process by whi ch normal cells are transformed to cancer cells.These cells have the prope rty of excessive growth and metastasis.Carcinogenesis may result from vari ous factors like mutation of the DNA.
\n\n3.Oncogenomics
\n\nCancer is a genetic disease&mdash\;that is\, cancer is caused by c ertain changes to genes that control the way our cells function\, especial ly how they grow and divide. Cancer is caused by certain changes to genes\ , the basic physical units of inheritance. Genetic changes that increase c ancer risk can be inherited from our parents if the changes are present in germ cells. Also\, inherited genetic mutations play a major role in about 5 to 10 per cent of all cancers.
\n\n4.Organ Based Cancers
\n\nCancer has a diversified nature in relation to the organ specif icity. Cancer is a group of more than 100 diseases that develop across tim e in virtually any of the body&rsquo\;s tissues. Each type of cancer has i ts unique features\; the basic processes that produce cancer are quite sim ilar in all forms of the disease. Organ Specific Cancers are cancers named basing on the location of cancer in the body organ. The various types of cancers include Head &\; Neck Cancer\, Lung Cancer\, Skin Cancer\, Brea st Cancer\, Bone Cancers\, Ovarian Cancer etc.
\n\n5.Hereditary Cancers
\n\nUsually referred as cancer syndrome this is a type of genetic disorder in which inherited gene mutations affect individuals t o form cancerous growth of cells and also early onset of cancer.These synd romes is caused by mutation in tumor suppressor genes.
\n\n6.Cancer Epigenetics
The study of epigenetic modifications to th e genome of cancer cells without changing the nucleotide sequence is refer red to as cancer epigenetics.Their manipulation helps a lot in detection o f cancer an its prevention.
\n\n7.Cancer Metastasis
\n\nMetastasis is the spread of a cancer or other disease from one organ or part of the body to another without being directly connected with it. Whe n cancer cells break away from a tumour\, they can travel to other areas o f the body through the bloodstream or the lymph system
\n\n8.Cancer Pharmacology
9.Cancer And The Immune System
\n\nIn most organs and tissues of a mature animal\, a balan ce is maintained between cell renewal and cell death. The various types of mature cells in the body have a given life span\; as these cells die\, ne w cells are generated by the proliferation and differentiation of various types of stem cells. This cell growth and proliferation are essential for wound healing and homeostasis. Under normal circumstances in the adult\, t he production of new cells is regulated so that the number of any particul ar type of cell remains fairly constant. Occasionally\, however\, cells ar ise that no longer respond to normal growth control mechanisms\; these cel ls proliferate in an unregulated manner\, giving rise to cancer
\n\n10.Cancer-Genomics And Metabolomi cs
\n\nCancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the gene tic basis of tumour cell proliferation and the evolution of the cancer gen ome under mutation and selection by the body environment\, the immune syst em and therapeutic interventions. The metabolites within a cell or biologi cal system are being used to analyze cancer metabolism on a system-wide sc ale\, painting a broad picture of the altered pathways and their interacti ons with each other. Cancer metabolomics involves chemical analysis by a r ange of analytical platforms through targeted/untargeted approaches. The a pplication of metabolomics towards cancer research has led to a renewed ap preciation of metabolism in cancer development and progression.
\n\n11.Cancer Therapy
\n\nCancer treatments are medical therapi es that claimed to treat cancer by different methods like surgery\, chemot herapy\, radiation oncology\, and immunotherapy. Oncolytic virotherapy is an emerging treatment method of cancer which uses viruses to destroy cance rs. The recent development in genetic engineering techniques has been made using viruses to attack and destroy cancer cells. Chemotherapy is a metho d of cancer treatments which uses chemical substances or chemotherapeutics drug to kill the cancerous cells. It is one of the major methods of medic al oncology.
\n\n12.Neuro-o ncology
\n\nNeuro-oncology is the study of brain and spinal cord neoplasms\, many of which are (at l east eventually) very dangerous and life-threatening (astrocytoma\, glioma \, glioblastoma multiforme\, ependymoma\, pontine glioma\, and brain stem tumors are among the many examples of these). Among the malignant brain ca ncers\, gliomas of the brainstem and pons\, glioblastoma multiforme\, and high-grade (highly anaplastic) astrocytoma are among the worst. In these c ases\, untreated survival usually amounts to only a few months\, and survi val with current radiation and chemotherapy treatments may extend that tim e from around a year to a year and a half\, possibly two or more\, dependi ng on the patient'\;s condition\, immune function\, treatments used\, a nd the specific type of malignant brain neoplasm.
\n\n13.Cancer Biomarkers
\n\n14.Novel Approaches Of Cancer Therapies< /em>
\n\nThe Normal treatment m odalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strateg ies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently\, cancer treatment is a highly dynamic field and sig nificant advances are being made in the development of novel cancer treatm ent strategies. In contrast to conventional cancer therapeutics\, novel ap proaches such as ligand or receptor based targeting\, intracellular drug t argeting\, gene delivery\, cancer stem cell therapy\, magnetic drug target ing and ultrasound-mediated drug delivery\, have added new modalities for cancer treatment.
\n\n15.Pr ecision Medicine And Cancer Therapy
\n\nCancers that are closely linked to certain behaviours are th e easiest to prevent. Many complementary health approaches are also there to combat the risks of cancers like&mdash\;for example\, herbal and other dietary supplements\, acupuncture\, massage\, and yoga.
\n\n< span style="color:#000000\;">16. Stem Cell Transplant Therapy
\n\nStem cell transplants do not u sually work against cancer directly. In cancer treatment high doses of che mo therapy and radiations are given to kill cancer cells\, but this also k ills the bone marrow stem cells .To replenish stem cells this stem cell th erapy is done which gives rise to healthy red blood cells.
\n\n< p>17.Cancer Management And Prevention\n\nCancers that are closely linked to certain behaviours are the easiest to prevent. Many complementa ry health approaches are also there to combat the risks of cancers like&md ash\;for example\, herbal and other dietary supplements\, acupuncture\, ma ssage\, and yoga.
\n\n18.Ca ncer Screening
\n\nScreeni ng of cancer refers to the detection of cancer before the symptoms appear. Screening procedure involves blood tests\, urine tests\, other tests\, or medical imaging. People having higher risk of developing cancer\, such as people with a family history of cancer are identified by selective screen ing.Mass screening involves screening everyone in a specific age group.
\n\n19. Alternative Medicine And Cancer
\n\nAlternative medicine or complementary medicine are practices claimed to have the heal ing effects of medicine but are disproven\, unproven\, impossible to prove \, or only harmful Alternative medicine consists of a wide variety of prac tices\, products\, and therapies&mdash\;ranging from those that are biolog ically plausible but not well tested\, to those with known harmful and tox ic effects. An even greater proportion of cancer patients use &ldquo\;comp lementary&rdquo\; therapies along with mainstream cancer treatment.
\n\n \;
\n\n20. Cancer Research
\n\nCancer resear ch definesbasic researchin cancer which is used in identifying the causes of cancer and developing novel strategies and new therapeutics for prevent ion\, diagnosis\, treatment\, and cure of cancer.Nowadays clinical cancer research has shifted towards therapies like cancer immunotherapy and gene therapy.
\n\n \;
\n\nTypes Of Cancer
\n\nA
\nAdenoid Cystic Carcin omaAdrenal Gland TumorAmyloidosisAnal CancerAtaxia-TelangiectasiaAtypical Mole SyndromeBBeckwith Wiedemann SyndromeBile Duct CancerBirt Hogg Dube Sy ndromeBladder CancerBone CancerBrain TumorBreast CancerBreast Cancer in Me nCCarcinoid TumorCarney ComplexCervical CancerColorectal CancerDDuctal Car cinomaEEndometrial CancerEsophageal CancerFFamilial-Adenomatous PolyposisG Gastric CancerGastrontestinal Stromal Tumor - GISTHHER2-Positive Breast Ca ncerHereditary Prostate CancerIIslet Cell TumorJJuvenile Polyposis Syndrom eKKaposi'\;s Sarcoma\, HIV and AIDSKidney CancerLLaryngeal CancerLeukem ia - Acute Lymphoblastic LeukemiaLeukemia - Acute Myeloid AMLLeukemia - Ad ultLeukemia - ChildhoodLeukemia - Chronic Lymphocytic - CLLLeukemia - Chro nic Myeloid - CMLLeukemia- Acute Lymphocytic (ALL)Liver CancerLobular Carc inomaLung CancerLung Cancer - Small CellLymphoma - Hodgkin'\;sLymphoma - Non-Hodgkin'\;sLynch SyndromeMMalignant GliomaMastocytosisMelanomaMen ingiomaMultiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Typ e 2Multiple MyelomaMyelodysplastic Syndrome (MDS)NNasopharyngeal CancerNeu roendocrine TumorNevoid Basal Cell Carcinoma SyndromeOOral CancerOsteosarc omaOvarian CancerPPancreatic CancerPancreatic Neuroendocrine TumorsParathy roid CancerPenile CancerPeritoneal CancerPeutz-Jeghers SyndromePituitary G land TumorPleuropulmonary Blastoma (Childhood)Polycythemia VeraProstate Ca ncerRRenal Cell CancerRetinoblastoma (Childhood)SSalivary Gland CancerSarc omaSarcoma - Alveolar Soft Part and CardiacSarcoma - KaposiSkin Cancer (No n-Melanoma)Small Bowel CancerSmall Intesine CancerSmall Intestine CancerSt omach CancerTTesticular CancerThymomaThyroid CancerTurcot SyndromeUUterine (Endometrial) CancerVVaginal CancerVon-Hippel-Lindau SyndromeWilms'\; Tumor (Childhood)XXeroderma Pigmentosum\n\nWorldwide Cancer Conferences
\n\nCancer \;Conferences \;in USA
\n\n4th \;Gynecologic Oncology Conferences &\; Pr eventive Oncology Conferences July 18-19\, 2021 Atlanta\, USA
\n \n11th International Hematology Conferenc es &\; Hematological Oncology Conferences November 08-09\, 2021 Las Veg as\, Nevada\, USA
\n\n7th World Breast Cancer Conferences November 1-2\, 2021 Toronto\, Canada
\n\nInternational Cancer Biology Conferen ces and Therapeutics Conferences October 23-24\, 2021 Ontario\, Canada
\n\nInternational Oncology Confere nces and Cancer Therapeutics Conferences October 30 - November 01\, 2021 I llinois\, USA
\n\nCancer Confer ences in Europe
\n\n4th World C ancer conferences and Cancer Prevention Methods Conferences April 19-21\, 2021 Valencia\, Spain
\n\nNCRI Cancer Conferences November 05-08\, 2021 Liverpool\, UK
\n\n< span style="color:#000000\;">Global Cancer Therapy Conferences August 07-0 9\, 2021 Frankfurt\, Germany
\n\nIn vivo model of Metastasis Conferences November 27-29\, 2021 Berlin\, G ermany
\n\nCancer Treatment Con ferences February 1-3\, 2021 Amsterdam\, Netherlands.
\n\nCancer \;Conferences \;in \;Asia
\n\n18th Asia Pacific Prostate Conferences Aug 30 - Sep 02\ , 2021 Melbourne
\n\n26th World Cancer Conference November 27-28\, 2021 Dubai\, UAE
\n\n32nd International Oncology Nursing Conferences a nd Cancer Care Conferences Sep 13-14\, 2021 Singapore
\n\n< span style="color:#000000\;">AORTIC International Cancer Conferences Novem ber 7-10\, 2021 Kigali\, Rwanda
\n\nESMO Africa Cancer Conference February 14-16\, 2021 Cape town\, South Africa
\n\nSASCeTS &\; Clin ical Haematology Society Cancer Conference November 4\, 2021
\n\ nSASCRO SASMO Cancer Conferences Sandton Convention Centre\, South Africa
\nWorldwide Cancer JournalsAnnals of OncologyAnti-Cancer DrugsAnticancer Re searchBiochimica et Biophysica ActaBMC CancerBreast Cancer ResearchBreast Cancer Research and TreatmentBritish Journal of CancerCancerCancer CellCan cer Epidemiology\, Biomarkers &\; PreventionCancer Immunology\, Immunot herapyCancer InformaticsCancer LettersCancer MedicineCancer Prevention Res earchCancer ResearchCancer ScienceCellClinical Breast CancerClinical Cance r ResearchEndocrine-Related CancerEuropean Journal of CancerEuropean Journ al of Cancer PreventionGenes\, Chromosomes and CancerIndian Journal of Can cerInternational Journal of CancerInternational Journal of OncologyInterna tional Journal of Radiation Oncology Biology PhysicsJournal of CancerJourn al of Cancer Research and Clinical OncologyJournal of Clinical OncologyJou rnal of Experimental &\; Clinical Cancer ResearchJournal of Oncology Pr acticeJournal of Surgical OncologyJournal of the National Cancer Institute Journal of Thoracic OncologyLeukemiaLung CancerMolecular Cancer ResearchNa tureNature Reviews CancerNature Reviews Clinical OncologyNeuro-OncologyNut rition and CancerOncology ReportsPediatric Hematology and OncologySupporti ve Care in CancerThe LancetTumor biology\n\nWorldwide Oncologists
\n\nOncologists in USA
\nCaliforn ia \;California Cancer Center City Of Hope Hospital Duarte - Comprehen sive Cancer Center Rebecca and John Moores UCSD Cancer CenterUCLA Jonsson Comprehensive Cancer Center UCSF Bakar Cancer Hospital \;Florida \ ;Children'\;s Center for Cancer &\; Blood Diseases Florida Hospital Cancer Institute Regional Cancer Center UF Health Shands Hospital Winter P ark Memorial Hospital Cancer Institute \;MarylandAlvin &\; Lois Lap idus Cancer Institute at Northwest Hospital Alvin and Lois Lapidus Cancer Institute At Sinai Hospital Center for Cancer and Blood Disorders Johns Ho pkins Hospital Oncology The Institute for Cancer Care at Mercy \;New Y orkMemorial Sloan Kettering Cancer Center New York Presbyterian Hospital C ancer Center New York Presbyterian Hospital Hem NYU Clinical Cancer Center Saint Luke'\;s-Roosevelt Hospital:Hematology/Oncology \;Washington Fred Hutchinson Cancer Research Center MultiCare Regional Cancer Center Ol ympic Medical Cancer Center Providence St. Mary Regional Cancer Center Spo kane CyberKnife &\; Radiation Oncology Center\n\nOncologists in Europe
\nUKBeatson West of Scotland Cancer Centre Bristol Haematology and O ncology Centre &emsp\;Cancer Centre London &emsp\;Clatterbridge Cancer Cen tre NHS Foundation Trust &emsp\;The Royal Marsden Hospital &emsp\;GermanyG erman Cancer Research Center &emsp\;UCCH Universitä\;res Cancer Center Hamburg\, UKE &emsp\;University Hospital Dresden &emsp\;University Hospit al Heidelberg &emsp\;University Medical Center Hamburg-Eppendorf &emsp\;Fr anceAmerican Hospital of Paris &emsp\;Centre Lé\;on Bé\;rard & emsp\;Centre Paul Strauss &emsp\;Fairview Breast Center &emsp\;Hô\;pi tal Institut Curie &emsp\;SpainClinical and Provincial Hospital of Barcelo na &emsp\;Hospital Universitario HM Madrid &emsp\;Institut Català\; d'\;Oncologia (ICO) &emsp\;MD Anderson Cancer Center Madrid &emsp\;Vall d'\;Hebron Institut d&rsquo\;Oncologia (VHIO) &emsp\;Greece"\;Thea genio"\; Cancer Hospital of Thessaloniki &emsp\;Agios Savvas General H ospital Hellenic Institute Against Cancer &emsp\;Interbalkan Medical Cente r &emsp\;Mediterraneo Hospital &emsp\;Metaxa Cancer Hospital of Piraeus &e msp\;\n\nOncologists in Asia
\nJapanAichi Cancer Center Chiba Univer sity Hospital National Cancer Center Hospital &emsp\;Shizuoka Cancer Cente r &emsp\;St. Luke'\;s International Hospital &emsp\;ChinaBeijing Cancer Hospital &emsp\;China-Japan Friendship Hospital &emsp\;Chinese Academy of Medical Sciences Cancer Hospital &emsp\;Guangzhou Fuda Cancer Hospital &e msp\;Modern Hospital Guangzhou &emsp\;AustraliaAustin Hospital\, Melbourne &emsp\;Genesis Cancer Care Bunbury &emsp\;Peter MacCallum Cancer Centre & emsp\;St Vincent'\;s Hospital\, Sydney &emsp\;The Kinghorn Cancer Centr e &emsp\;IndiaCachar Cancer Hospital and Research Centre &emsp\;Central In dia Institute of Haematology &\; Oncology &emsp\;Kidwai Memorial Instit ute of Oncology &emsp\;Rajiv Gandhi Cancer Institute &\; Research Centr e &emsp\;Tata Memorial Centre &emsp\;South KoreaAsan Medical Center &emsp\ ;Gangnam Severance Hospital &emsp\;International healthcare center\, Seoul National University Hospital &emsp\;Seoul National University Hospital &e msp\;Severance Hospital &emsp\;\n\nOncologists in Africa
\nNigeriaDi vine Medical Center Ltd. Lakeshore Cancer Center Marie Stopes Internationa l Organisation Nigeria (MSION) National Hospital\, Abuja Primus Internatio nal Super Specialty Hospital \;South AfricaCancer Association of South Africa CANSA G V I Oncology Netcare Unitas Hospital Sandton Oncology  \;EgyptChildren'\;s Cancer Hospital Egypt Dar Al Fouad &emsp\;Queens Ho spital &emsp\;Saudi German Hospital - Cairo &emsp\;The Egyptian Hospital & emsp\;AlgeriaBoufarik hospital &emsp\;Clinique Mohamed El Mehdi &emsp\;Hos pital Ben Aknoun Boukhroufa Abdelkader &emsp\;Hospital Center And Universi ty D'\;oran &emsp\;Mustapha Pacha hospital \;MoroccoCenter Diagnost ic Cancer Du Sein Center Oncology Ahmed Ben Zayd Center Oncology Hospital Cheikh Zaid Ibn Tofail University Hospital.